Satoshi Yasuda

Showing 1-3 of 3 articles

Coronary interventions

Biodegradable polymer-based, argatroban-eluting, cobalt-chromium stent (JF-04) for treatment of native coronary lesions: final results of the first-in-man study and lessons learned

Morino Y, Tobaru T, Yasuda S, Kataoka K, Tanabe K, Hirohata A, Kozuma K, Kimura T

November 20, 2016 | 10.4244/EIJV12I10A208

Coronary interventions

Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial

Onuma Y, Sotomi Y, Shiomi H, Ozaki Y, Namiki A, Yasuda S, Ueno T, Ando K, Furuya J, Igarashi K, Kozuma K, Tanabe K, Kusano H, Rapoza R, Popma J, Stone G, Simonton C, Serruys P, Kimura T

October 20, 2016 | 10.4244/EIJY16M09_01

Impact of end-stage renal disease in patients with critical limb ischaemia undergoing infrapopliteal intervention

Kawarada O, Yokoi Y, Higashimori A, Fujihara M, Sakamoto S, Ishihara M, Yasuda S, Ogawa H

October 20, 2014 | 10.4244/EIJV10I6A129

1

Latest news

Robotics, AI and Imaging State of The Art; Bleeding Risk and Mortality in CAD; Treating Refractory Angina by Coronary Sinus Narrowing; and more

September 20, 2021

STATE OF THE ART

Robotics, imaging, and artificial intelligence in the catheterisation laboratory

Rafael Beyar et al.

September 20, 2021

ViV TAVI vs repeat SAVR

Monil Majmundar et al.

September 15, 2021

Thrombectomy for ischaemic stroke

Christopher A. Rajkumar et al.

September 10, 2021

Walking the tightrope between ischaemia and bleeding

Michelle L. O’Donoghue et al.

September 20, 2021

Microvascular dysfunction endotypes and outcomes

Christos V. Bourantas et al.

September 20, 2021

Coronary sinus reducer therapy for refractory angina: is it ready for prime time?

Michael Foley et al.

September 20, 2021

Valvular disease